Service Corporation International (SCI) 47th Annual Raymond James Institutional Investor Conference summary
Event summary combining transcript, slides, and related documents.
47th Annual Raymond James Institutional Investor Conference summary
3 Mar, 2026Company overview and industry positioning
Operates about 2,000 funeral and cemetery locations in North America, with a strong focus on major metropolitan areas and middle to upper spend categories.
Holds a unique, hard-to-duplicate network of 500 large cemeteries, many with significant acreage in urban centers.
Maintains a $17–$18 billion backlog of future revenues from pre-need contracts, positioning for long-term growth.
Revenue growth currently driven by low single-digit increases in average sale price and strong pre-need cemetery sales.
EPS growth averaged 13–14% CAGR pre-COVID, with normalization post-pandemic.
COVID-19 impact and operational changes
COVID accelerated technology adoption, including customer-facing applications and virtual sales tools.
Sales force was streamlined from 4,300 to 3,800 counselors, increasing efficiency and sales production.
Consumer demand for full-service funerals remained strong, reinforcing the value of service offerings.
Cost synergies and operational efficiencies realized during the pandemic have been sustained.
M&A strategy and capital allocation
Focus shifted from large transformative deals to mid-level M&A in major markets and share repurchases.
Nearly 60% of shares repurchased over 20 years, reducing outstanding shares from 340 million to under 140 million.
Annual M&A spend is about $100 million, targeting large independents in metropolitan areas for scale benefits.
Private equity activity is mostly in rural, lower-volume businesses, not directly competing for core targets.
Strong pipeline of potential deals, with continued investment in new construction ($60–$80 million/year).
Latest events from Service Corporation International
- Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Earnings growth, robust M&A, and tech-driven efficiency position the business for strong future gains.SCI
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Strong market position, robust returns, and growth driven by scale and preneed strategy.SCI
Investor presentation13 Jan 2026 - Industry leader with strong cash flow, superior returns, and 2025 EPS growth aligned with targets.SCI
Investor presentation13 Jan 2026